- Home
- EDRY vs MODD Comparison
EDRY vs MODD Comparison
Compare EDRY & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDRY
- MODD
- Stock Information
- Founded
- EDRY 2018
- MODD 1998
- Country
- EDRY Greece
- MODD United States
- Employees
- EDRY 296
- MODD N/A
- Industry
- EDRY Marine Transportation
- MODD Industrial Specialties
- Sector
- EDRY Consumer Discretionary
- MODD Health Care
- Exchange
- EDRY Nasdaq
- MODD Nasdaq
- Market Cap
- EDRY 24.6M
- MODD 35.5M
- IPO Year
- EDRY N/A
- MODD N/A
- Fundamental
- Price
- EDRY $8.47
- MODD $0.92
- Analyst Decision
- EDRY
- MODD
- Analyst Count
- EDRY 0
- MODD 0
- Target Price
- EDRY N/A
- MODD N/A
- AVG Volume (30 Days)
- EDRY 4.2K
- MODD 122.6K
- Earning Date
- EDRY 05-20-2025
- MODD 02-13-2025
- Dividend Yield
- EDRY N/A
- MODD N/A
- EPS Growth
- EDRY N/A
- MODD N/A
- EPS
- EDRY N/A
- MODD N/A
- Revenue
- EDRY $61,083,227.00
- MODD N/A
- Revenue This Year
- EDRY N/A
- MODD N/A
- Revenue Next Year
- EDRY $42.57
- MODD N/A
- P/E Ratio
- EDRY N/A
- MODD N/A
- Revenue Growth
- EDRY 28.35
- MODD N/A
- 52 Week Low
- EDRY $8.00
- MODD $0.68
- 52 Week High
- EDRY $24.84
- MODD $2.65
- Technical
- Relative Strength Index (RSI)
- EDRY 38.47
- MODD 48.62
- Support Level
- EDRY $8.40
- MODD $0.79
- Resistance Level
- EDRY $9.50
- MODD $0.95
- Average True Range (ATR)
- EDRY 0.59
- MODD 0.10
- MACD
- EDRY -0.02
- MODD 0.00
- Stochastic Oscillator
- EDRY 30.52
- MODD 55.12
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulks such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.